Genus PLC reported a strong fiscal year ending June 2026, with adjusted pre-tax profit up 35% to £100.2m and revenue steady at £658.1m. The company also announced a £60m share buyback and increased its dividend by 10%. Despite these positive results, shares fell 7% due to market reactions. Analysts remain optimistic, highlighting growth potential from Genus's pig respiratory disease-resistance technology (PRP) progressing through regulatory approvals and early commercialization in Latin America. Forecasts for the next year suggest moderate profit growth amid tougher agricultural markets.
Lisk is shutting down its original Lisk Chain on October 31, 2026, requiring holders with LSK tokens on that chain or staked there to bridge their tokens to Ethereum by October 21, 2026. This deadline accounts for a three-day unstaking period plus a ...
The Invesco Global Clean Energy ETF (PBD) tracks the WilderHill NEX Index, providing investors with global clean energy exposure compared to the more US-centric PBW ETF. PBD's broader international diversification results in lower short- and medium-t...
Ethereum developers Vitalik Buterin and Thomas Coratger proposed EIP-8288, a draft plan to reduce the high gas costs of advanced cryptography on Ethereum by aggregating multiple STARK proofs into a single proof. This method shifts much of the cryptog...
XRP Ledger developers plan to make their blockchain fully resistant to quantum computing threats by 2028, a year ahead of Ethereum's similar goal set for 2029. Their approach includes native key rotation to keep user addresses unchanged, an emergency...
Daniel Francis is a technical writer and educator specializing in Web3, macroeconomics, and decentralized finance (DeFi). Active in the crypto space since 2017, he uses on-chain analytics to produce evidence-based reports and guides. Holding certific...
